Authors/Disclosures
|
Dongxian Zhang, PhD
(Burnham Institute for Medical Research)
|
No disclosure on file |
|
|
No disclosure on file |
|
Natalie J. Engmann, PhD
(Genentech, Inc)
|
No disclosure on file |
|
|
No disclosure on file |
|
Corey McMillan, PhD
(University of Pennsylvania)
|
Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Katya Rascovsky
(University of Pennsylvania Perelman School of Medicine)
|
No disclosure on file |
|
|
No disclosure on file |
|
Jacqueline Rick
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Daniel Weintraub
|
Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care. |
|
Stuart A. Lipton, MD, PhD, FAAN
(The Scripps Research Institute)
|
Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Deerfield Management. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Panorama Research, Inc.. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Circumvent Therapeutics, Inc.. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Harvard Medical School/Boston Children's Hostpial. Dr. Lipton has stock in EuMentis Therapeutics, Inc.. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from CIRM California Institute for Regenerative Medicine. The institution of Dr. Lipton has received research support from TRDRP California Tobacco Related Research/UCOP. The institution of Dr. Lipton has received research support from Circumvent Pharmaceuticals. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has a non-compensated relationship as a Associate Editor with Neuron (Cell Press) that is relevant to AAN interests or activities. |
|
Murray Grossman, MD, FAAN
(University of Pennsylvania)
|
Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH. |
|
Pablo Bonardo, MD
|
Dr. Bonardo has nothing to disclose. |